117 related articles for article (PubMed ID: 7535890)
1. Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum.
Francis JW; Von Visger J; Markelonis GJ; Oh TH
Neurotoxicol Teratol; 1995; 17(1):7-12. PubMed ID: 7535890
[TBL] [Abstract][Full Text] [Related]
2. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
Watanabe Y; Kato H; Araki T
Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
O'Callaghan JP; Miller DB; Reinhard JF
Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
[TBL] [Abstract][Full Text] [Related]
4. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice.
Himeda T; Watanabe Y; Tounai H; Hayakawa N; Kato H; Araki T
J Neural Transm (Vienna); 2006 Dec; 113(12):1887-94. PubMed ID: 16736245
[TBL] [Abstract][Full Text] [Related]
5. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
6. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
Otto D; Unsicker K
Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
[TBL] [Abstract][Full Text] [Related]
7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP.
O'Callaghan JP; Miller DB; Reinhard JF
Neurosci Lett; 1990 Sep; 117(1-2):228-33. PubMed ID: 1981254
[TBL] [Abstract][Full Text] [Related]
8. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
9. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
[TBL] [Abstract][Full Text] [Related]
10. Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice. Are the striatal astrocytes regionally activated after systemic MPTP administration?
Chen LW; Wei LC; Qiu Y; Liu HL; Rao ZR; Ju G; Chan YS
Brain Res; 2002 Jan; 925(1):9-17. PubMed ID: 11755896
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry.
Strömberg I; Björklund H; Dahl D; Jonsson G; Sundström E; Olson L
Brain Res Bull; 1986 Aug; 17(2):225-36. PubMed ID: 3094835
[TBL] [Abstract][Full Text] [Related]
12. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Chen LW; Hu HJ; Liu HL; Yung KK; Chan YS
Neuroscience; 2004; 126(4):941-53. PubMed ID: 15207328
[TBL] [Abstract][Full Text] [Related]
13. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
[TBL] [Abstract][Full Text] [Related]
14. MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice.
Costa G; Frau L; Wardas J; Pinna A; Plumitallo A; Morelli M
Mov Disord; 2013 Dec; 28(14):1957-65. PubMed ID: 24108425
[TBL] [Abstract][Full Text] [Related]
15. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
Reinhard JF; Miller DB; O'Callaghan JP
Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
[TBL] [Abstract][Full Text] [Related]
16. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
Chadi G; Møller A; Rosén L; Janson AM; Agnati LA; Goldstein M; Ogren SO; Pettersson RF; Fuxe K
Exp Brain Res; 1993; 97(1):145-58. PubMed ID: 7907549
[TBL] [Abstract][Full Text] [Related]
17. Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice.
Takagi S; Hayakawa N; Kimoto H; Kato H; Araki T
J Neural Transm (Vienna); 2007; 114(12):1553-7. PubMed ID: 17676428
[TBL] [Abstract][Full Text] [Related]
18. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
O'Callaghan JP; Martin PM; Mass MJ
Ann N Y Acad Sci; 1998 May; 844():40-9. PubMed ID: 9668663
[TBL] [Abstract][Full Text] [Related]
19. Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.
Bagga P; Crescenzi R; Krishnamoorthy G; Verma G; Nanga RP; Reddy D; Greenberg J; Detre JA; Hariharan H; Reddy R
J Neurochem; 2016 Nov; 139(3):432-439. PubMed ID: 27529288
[TBL] [Abstract][Full Text] [Related]
20. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
Ferger B; Leng A; Mura A; Hengerer B; Feldon J
J Neurochem; 2004 May; 89(4):822-33. PubMed ID: 15140182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]